• Medicine
• Published in
  Annals of oncology : official…
  2000
• DOI:10.1023/A:1008337103708

A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: a Japanese cooperative study.

@article{Katsumata2000API,
  title={A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: a Japanese cooperative study.},
  author={Noriyuki Katsumata and Ryuichiro Tsunematsu and K Tanaka and Yasushi Terashima and Shin Ogita and Hiroshi Hoshiai and Ichiro Kohno and Kouji Hirabayashi and Masashi Yakushiji and Kiichiro Noda and Tetsuo Taguchi},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2000},
  volume={11 12},
  pages={
          1531-6
        }
}

• Noriyuki Katsumata, Ryuichiro Tsunematsu, +8 authors Tetsuo Taguchi

BACKGROUND This phase II study was conducted to evaluate the efficacy and toxicity of docetaxel in Japanese patients with advanced ovarian cancer. PATIENTS AND METHODS Docetaxel was administered at a dose of 70 mg/m2 intravenously to patients with platinum pretreated advanced ovarian cancer. Treatment was repeated every three weeks. No routine corticosteroid premedication was given. RESULTS Ninety patients with advanced ovarian cancer were entered and sixty were assessable for response. The… CONTINUE READING

View PDF

Save to Library

Create Alert

Cite